Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $130.72 USD
Change Today +0.07 / 0.05%
Volume 1.2M
EW On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

edwards lifesciences corp (EW) Key Developments

Edwards Lifesciences Corp. - Shareholder/Analyst Call

Annual Meeting Of Stockholders

Edwards Lifesciences Corporation Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for Second Quarter of 2015; Revises Earnings Guidance for the Full Year 2015

Edwards Lifesciences Corporation reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net sales of $590.3 million against $522.4 million a year ago. Income before provision for income taxes was $162.5 million against $77.3 million a year ago. Net income was $123.4 million or $1.12 per diluted share against $60.3 million or $0.56 per diluted share a year ago. Non-GAAP net income was $123.7 million or $1.12 per diluted share against $82.1 million or $0.76 per diluted share a year ago. Cash flow from operating activities for the quarter was $73.3 million. After capital spending of $20.8 million, free cash flow was $52.5 million. The company now expected full year 2015 total sales to be within its original guidance of $2.3 billion to $2.5 billion. The company narrowed its guidance for full year 2015 diluted earnings per share, excluding special items, to a range of $4.10 to $4.30, from its previous range of $4.00 to $4.30. The company continued to expect full year tax rate, excluding special items, to be between 21% and 23%. For full year 2015, the company continued to expect free cash flow, excluding special items, to be between $375 million and $425 million. For the second quarter of 2015, at current foreign exchange rates, the company projects total sales to be between $580 million and $620 million, and diluted earnings per share, excluding special items, to be between $1.00 and $1.10.

Edwards Lifesciences Corp. Presents at Sanford C. Bernstein Thirty-First Annual Strategic Decisions Conference 2015, May-28-2015 02:00 PM

Edwards Lifesciences Corp. Presents at Sanford C. Bernstein Thirty-First Annual Strategic Decisions Conference 2015, May-28-2015 02:00 PM. Venue: The Waldorf Astoria Hotel, 301 Park Avenue (between 49th and 50th Street), New York, New York, United States. Speakers: Michael A. Mussallem, Chairman and Chief Executive Officer.

Edwards Lifesciences Corp. to Report Q1, 2015 Results on Apr 23, 2015

Edwards Lifesciences Corp. announced that they will report Q1, 2015 results at 5:00 PM, US Eastern Standard Time on Apr 23, 2015

Edwards Lifesciences Corp., Q1 2015 Earnings Call, Apr 23, 2015

Edwards Lifesciences Corp., Q1 2015 Earnings Call, Apr 23, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EW:US $130.72 USD +0.07

EW Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $170.32 USD -0.38
Endo International PLC $83.76 USD +0.82
Hologic Inc $35.77 USD +0.48
Intuitive Surgical Inc $487.75 USD +1.95
Mettler-Toledo International Inc $324.68 USD -3.50
View Industry Companies
 

Industry Analysis

EW

Industry Average

Valuation EW Industry Range
Price/Earnings 16.3x
Price/Sales 5.9x
Price/Book 6.3x
Price/Cash Flow 16.1x
TEV/Sales 5.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EDWARDS LIFESCIENCES CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.